Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Jasmin V. Waterhouse"'
Autor:
Jasmin V Waterhouse, Jasmine Pattarukuzhyil Jose, Nikki Snuggs, Annette White, Kate Harper, Marieke van Leeuwen, Alistair Ring
Publikováno v:
Cancer Research. 83:P5-08
Background An increasing number of patients survive their early breast cancer (EBC) but may experience longer term impact on their quality of life (QoL) arising from their diagnosis and treatment. Survivors are also at risk of other possibly life-sho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f08146ec066a38c5305ebb8f839641cd
https://doi.org/10.1158/1538-7445.sabcs22-p5-08-12
https://doi.org/10.1158/1538-7445.sabcs22-p5-08-12
Autor:
Jasmin V Waterhouse, Catherine A. Welch, Nicolo M.L. Battisti, David Adlam, Michael J. Sweeting, Lizz Paley, Paul Lambert, John E. Deanfield, Mark de Belder, Michael D Peake, Alistair Ring
Publikováno v:
Cancer Research. 83:P6-08
Background In England, as for many countries, there are geographical variations in treatment uptake and outcomes for patients with early breast cancer (EBC). It is important such inequalities are addressed. The co-existence of cardiovascular disease
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5e458d3b0047d903b54ae17eedd23c5c
https://doi.org/10.1158/1538-7445.sabcs22-p6-08-04
https://doi.org/10.1158/1538-7445.sabcs22-p6-08-04
Publikováno v:
European Urology
The current World Health Organization guidance is not to start corticosteroids, but there is no robust evidence of risk in patients with cancer and coronavirus disease 2019. A risk-benefit analysis should be performed for each patient on the use of s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4eccdc9190337ae9bc5e480e8eb53b63
Autor:
Yaalini Shanmugabavan, Bihani Kularatne, Andrew Rowan, Michelle Hung, Javier Herrero, Ayse U. Akarca, Gerhardt Attard, Hashim U. Ahmed, Sergio A. Quezada, Nicholas McGranahan, Mark Linch, Rachel Rosenthal, Alex Freeman, Anuradha Jayaram, Charles Swanton, Yien Ning Sophia Wong, Teresa Marafioti, Mark Emberton, Gerald Goh, Jasmin V. Waterhouse
Publikováno v:
Journal of Clinical Oncology. 38:e17500-e17500
e17500 Background: IT heterogeneity (ITH) is well recognised in prostate cancer (PC), but its role in high-risk disease and patient outcomes are uncertain. Methods: This was a prospective, single-arm, translational study using targeted multi-region p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b63e9af9e481421f7cd8e729cff02246
https://doi.org/10.1200/jco.2020.38.15_suppl.e17500
https://doi.org/10.1200/jco.2020.38.15_suppl.e17500